Kobl373
_
510 (k} Summary

This summary of 510(k) safety and effectiveness information is being submitted in
accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

Date Prepared: 15 May 2006

AUG 0 2 2006

510(k) number:

Applicant Information:

VNUS Medical Technologies, Inc.

5799 Fontanoso Way

San Jose, CA 95138

Contact Person: Carelle Karimimanesh

Phone Number: (408) 360-7261

Fax Number: (408) 365-8480

Device Information:

Classification: Class il

Trade Name: VNUS® ClosureFAST™ Catheter

Classification Name: Electrosurgical Device (21 CFR §878.4400)

Equivaient Device:

The subject device is substantially equivalent in intended use and/or method of
operation to the VNUS® ClosurePlus™ Catheter (K030557).

The technological characteristics and principals of operation of the VNUS ClosureFAST
catheter are substantially equivalent to the noted predicate device. Both devices rely on
the delivery of RF energy to an intravascular catheter that heats a blood vessel to a
specific temperature to achieve the intended use.

Intended Use: :
The VNUS® ClosureFAST™ Catheter is intended for endovascular coagulation of blood
vessels in patients with superficial vein reflux.

Test Results:

Performance

Results of in vitro testing demonstrate that the VNUS ClosureFAST catheter is
substantially equivalent to the predicate device effective for its intended function.
Biocompatibility

The materials used in the VNUS ClosureFAST Catheters have been shown to be
biocompatible. .

Summary:

Based on the intended use, product performance, and biocompatibility information
provided in this notification, the subject device has been shown to be substantially
equivalent to the currently marketed predicate device. :
CONFIDENTIAL Page C-2

i ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
noe Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850
VNUS Medical Technologies, Inc. AUG G 1 2006
% Carelle Karimimanesh
Director, Regulatory Affairs
2200 Zanker Road, Suite F
San Jose, California 95131
Re: K061373
Trade/Device Name: VNUS® ClosureFAST™
Regulatory Number: 21 CFR 878.4400
Regulatory Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: II
Product Code: GEI
Dated: May 15, 2006
Received: May 17, 2006
Dear Carelle Karimimanesh:
We have reviewed your Section 510(k) premarket notification of intent to market the device
teferenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
gencral controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class HI (PMA). it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21. Parts 800 to 898. In addition. FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of 4 substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CER Part 807); labeling (21 CFR Part 801): good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable. the electronic
product radiation control provisions (Sections 531-342 of the Act): 21 CFR 1000-1050.

Page 2 — Carelle Karimimanesh
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
“Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

haber Prete

Mark N. Melkerson
, Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

VNUS Medical Technologies, Inc. ClosureFAST™ Premarket Notification
Device Name: VNUS® ClosureFAST™ 510(k) Number: K061373
Catheter
Indications for Use:
The VNUS® ClosureFAST™ Catheter is intended for endovascular coagulation of
blood vessels in patients with superficial vein reflux.
Prescription Use: or Over the Counter Use:
(21 CFR §801 Subpart D) (21 CFR §801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
CONCURRENCE OF CDRH, OFFICE OF DEVICE EVALUATION (ODE) j
MA AGI p i py fa fh
ttl A eli?
(Division Sign- Divisi ‘ .
sion of General, Restorative,
and Neurological Devices
510(k) Number le (> 7S
nn aac
CONFIDENTIAL Page C-2

